{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:05:35Z","timestamp":1789506335227,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21837001, 21740002"],"award-info":[{"award-number":["21837001, 21740002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Conquering the mutational drug resistance is a great challenge in anti-HIV drug development and therapy. Quantitatively predicting the mutational drug resistance in molecular level and elucidating the three dimensional structure-resistance relationships for anti-HIV drug targets will help to improve the understanding of the drug resistance mechanism and aid the design of resistance evading inhibitors. Here the MB-QSAR (Mutation-dependent Biomacromolecular Quantitative Structure Activity Relationship) method was employed to predict the molecular drug resistance of HIV-1 protease mutants towards six drugs, and to depict the structure resistance relationships in HIV-1 protease mutants. MB-QSAR models were constructed based on a published data set of <jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> values for HIV-1 protease mutants against drugs. Reliable MB-QSAR models were achieved and these models display both well internal and external prediction abilities. Interpreting the MB-QSAR models supplied structural information related to the drug resistance as well as the guidance for the design of resistance evading drugs. This work showed that MB-QSAR method can be employed to predict the resistance of HIV-1 protease caused by polymorphic mutations, which offer a fast and accurate method for the prediction of other drug target within the context of 3D structures.<\/jats:p>","DOI":"10.1038\/s41598-022-07012-x","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T11:23:53Z","timestamp":1645442633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prediction and molecular field view of drug resistance in HIV-1 protease mutants"],"prefix":"10.1038","volume":"12","author":[{"given":"Baifan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinwu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"7012_CR1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/337615a0","volume":"337","author":"MA Navia","year":"1989","unstructured":"Navia, M. A. et al. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337, 615\u2013620 (1989).","journal-title":"Nature"},{"key":"7012_CR2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/337576a0","volume":"337","author":"M Miller","year":"1989","unstructured":"Miller, M., Jask\u00f3lski, M., Rao, J. K., Leis, J. & Wlodawer, A. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337, 576\u2013579 (1989).","journal-title":"Nature"},{"key":"7012_CR3","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1073\/pnas.87.22.8805","volume":"87","author":"AL Swain","year":"1990","unstructured":"Swain, A. L. et al. X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor. Proc. Natl. Acad. Sci. USA 87, 8805\u20138809 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"7012_CR4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.bi.62.070193.002551","volume":"62","author":"A Wlodawer","year":"1993","unstructured":"Wlodawer, A. & Erickson, J. W. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62, 543\u2013585 (1993).","journal-title":"Annu. Rev. Biochem."},{"key":"7012_CR5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pa.36.040196.002553","volume":"36","author":"JW Erickson","year":"1996","unstructured":"Erickson, J. W. & Burt, S. K. Structural mechanisms of HIV drug resistance. Annu. Rev. Pharmacol. Toxicol. 36, 545\u2013571 (1996).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"7012_CR6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00002030-199806000-00010","volume":"12","author":"JC Walsh","year":"1998","unstructured":"Walsh, J. C., Jones, C. D., Barnes, E. A., Gazzard, B. G. & Mitchell, S. M. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors. AIDS 12, 613\u2013618 (1998).","journal-title":"AIDS"},{"key":"7012_CR7","first-page":"a007161","volume":"2","author":"EJ Arts","year":"2012","unstructured":"Arts, E. J. & Hazuda, D. J. HIV-1 antiretroviral drug therapy. Cold Spring Harb. Perspect. Med. 2, a007161 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"7012_CR8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2018.07.020","volume":"158","author":"S Mason","year":"2018","unstructured":"Mason, S., Devincenzo, J. P., Toovey, S., Wu, J. Z. & Whitley, R. J. Comparison of antiviral resistance across acute and chronic viral infections. Antivir. Res. 158, 103\u2013112 (2018).","journal-title":"Antivir. Res."},{"key":"7012_CR9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0042-6822(03)00484-7","volume":"314","author":"NG Hoffman","year":"2003","unstructured":"Hoffman, N. G., Schiffer, C. A. & Swanstrom, R. Covariation of amino acid positions in HIV-1 protease. Virology 314, 536\u2013548 (2003).","journal-title":"Virology"},{"key":"7012_CR10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1128\/AAC.49.5.2015-2025.2005","volume":"49","author":"V Svicher","year":"2005","unstructured":"Svicher, V. et al. Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors. Antimicrob. Agents Chemother. 49, 2015\u20132025 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"7012_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","volume":"350","author":"F Clavel","year":"2004","unstructured":"Clavel, F. & Hance, A. J. Medical progress: HIV drug resistance. N. Engl. J. Med. 350, 1023\u20131035 (2004).","journal-title":"N. Engl. J. Med."},{"key":"7012_CR12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.antiviral.2009.07.006","volume":"85","author":"L Menendez-Arias","year":"2010","unstructured":"Menendez-Arias, L. Molecular basis of human immunodeficiency virus drug resistance: An update. Antivir. Res. 85, 210\u2013231 (2010).","journal-title":"Antivir. Res."},{"key":"7012_CR13","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/v2112509","volume":"2","author":"A Ali","year":"2010","unstructured":"Ali, A. et al. Molecular basis for drug resistance in HIV-1 protease. Viruses-Basel 2, 2509\u20132535 (2010).","journal-title":"Viruses-Basel"},{"key":"7012_CR14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/00002030-200308150-00008","volume":"17","author":"F Brun-V\u00e9zinet","year":"2003","unstructured":"Brun-V\u00e9zinet, F. et al. Clinically relevant interpretation of genotype for resistance to abacavir. AIDS 17, 1795\u20131802 (2003).","journal-title":"AIDS"},{"key":"7012_CR15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000331998","volume":"55","author":"MW Tang","year":"2012","unstructured":"Tang, M. W., Liu, T. F. & Shafer, R. W. The HIVdb system for HIV-1 genotypic resistance interpretation. Intervirology 55, 98\u2013101 (2012).","journal-title":"Intervirology"},{"key":"7012_CR16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350200700206","volume":"7","author":"K Van Laethem","year":"2002","unstructured":"Van Laethem, K. et al. A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients. Antivir. Ther. 7, 123\u2013129 (2002).","journal-title":"Antivir. Ther."},{"key":"7012_CR17","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1093\/nar\/gkg575","volume":"31","author":"N Beerenwinkel","year":"2003","unstructured":"Beerenwinkel, N. et al. Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic acids Res. 31, 3850\u20133855 (2003).","journal-title":"Nucleic acids Res."},{"key":"7012_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-016-1179-2","volume":"17","author":"M Riemenschneider","year":"2016","unstructured":"Riemenschneider, M., Hummel, T. & Heider, D. SHIVA-a web application for drug resistance and tropism testing in HIV. BMC Bioinform. 17, 1\u20136 (2016).","journal-title":"BMC Bioinform."},{"key":"7012_CR19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1359-6446(05)03377-5","volume":"10","author":"Z Cao","year":"2005","unstructured":"Cao, Z. et al. Computer prediction of drug resistance mutations in proteins. Drug Discov. Today 10, 521\u2013529 (2005).","journal-title":"Drug Discov. Today"},{"key":"7012_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18388\/pb.2016_26","volume":"62","author":"IT Weber","year":"2016","unstructured":"Weber, I. T. & Harrison, R. W. Tackling the problem of HIV drug resistance. Postepy Biochem. 62, 273\u2013279 (2016).","journal-title":"Postepy Biochem."},{"key":"7012_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/135965350501000115","volume":"10","author":"E Jenwitheesuk","year":"2005","unstructured":"Jenwitheesuk, E. & Samudrala, R. Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach. Antivir. Ther. 10, 157\u2013166 (2005).","journal-title":"Antivir. Ther."},{"key":"7012_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2011.08.005","volume":"92","author":"JS Toor","year":"2011","unstructured":"Toor, J. S. et al. Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis. Antivir. Res. 92, 213\u2013218 (2011).","journal-title":"Antivir. Res."},{"key":"7012_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255693","volume":"16","author":"R Ota","year":"2021","unstructured":"Ota, R., So, K., Tsuda, M., Higuchi, Y. & Yamashita, F. Prediction of HIV drug resistance based on the 3D protein structure: Proposal of molecular field mapping. PLoS ONE 16, e0255693. https:\/\/doi.org\/10.1371\/journal.pone.0255693 (2021).","journal-title":"PLoS ONE"},{"key":"7012_CR24","doi-asserted-by":"crossref","first-page":"e0168616","DOI":"10.1371\/journal.pone.0168616","volume":"11","author":"J Agniswamy","year":"2016","unstructured":"Agniswamy, J., Louis, J. M., Roche, J., Harrison, R. W. & Weber, I. T. Structural studies of a rationally selected multi-drug resistant HIV-1 protease reveal synergistic effect of distal mutations on flap dynamics. PLoS ONE 11, e0168616 (2016).","journal-title":"PLoS ONE"},{"key":"7012_CR25","first-page":"1","volume":"8","author":"OS Amamuddy","year":"2018","unstructured":"Amamuddy, O. S., Bishop, N. T. & Bishop, \u00d6. T. Characterizing early drug resistance-related events using geometric ensembles from HIV protease dynamics. Sci. Rep. 8, 1\u201311 (2018).","journal-title":"Sci. Rep."},{"key":"7012_CR26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/acs.jcim.5b00667","volume":"56","author":"A Hosseini","year":"2016","unstructured":"Hosseini, A. et al. Computational prediction of HIV-1 resistance to protease inhibitors. J. Chem. Inf. Model. 56, 915\u2013923 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"7012_CR27","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1021\/acschembio.9b00370","volume":"14","author":"M Henes","year":"2019","unstructured":"Henes, M. et al. Picomolar to micromolar: Elucidating the role of distal mutations in HIV-1 protease in conferring drug resistance. ACS Chem. Biol. 14, 2441\u20132452 (2019).","journal-title":"ACS Chem. Biol."},{"key":"7012_CR28","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/jp102546s","volume":"114","author":"G Hao","year":"2010","unstructured":"Hao, G., Yang, G. & Zhan, C. Computational mutation scanning and drug resistance mechanisms of HIV-1 protease inhibitors. J. Phys. Chem. B 114, 9663\u20139676 (2010).","journal-title":"J. Phys. Chem. B"},{"key":"7012_CR29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/cjoc.201300417","volume":"31","author":"Y He","year":"2013","unstructured":"He, Y., Niu, C., Wen, X. & Xi, Z. Molecular drug resistance prediction for acetohydroxyacid synthase mutants against chlorsulfuron using MB-QSAR. Chin. J. Chem. 31, 1171\u20131180 (2013).","journal-title":"Chin. J. Chem."},{"key":"7012_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/minf.201200144","volume":"32","author":"Y He","year":"2013","unstructured":"He, Y., Niu, C., Wen, X. & Xi, Z. Biomacromolecular 3D-QSAR to decipher molecular herbicide resistance in acetohydroxyacid synthases. Mol. Inform. 32, 139\u2013144 (2013).","journal-title":"Mol. Inform."},{"key":"7012_CR31","doi-asserted-by":"crossref","first-page":"12729","DOI":"10.1021\/acs.jafc.0c04947","volume":"68","author":"Z Pang","year":"2020","unstructured":"Pang, Z. et al. Comparative studies of potential binding pocket residues reveal the molecular basis of ShHTL receptors in the perception of GR24 in Striga. J. Agric. Food Chem. 68, 12729\u201312737 (2020).","journal-title":"J. Agric. Food Chem."},{"key":"7012_CR32","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer","year":"1988","unstructured":"Cramer, R. D., Patterson, D. E. & Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110, 5959\u20135967 (1988).","journal-title":"J. Am. Chem. Soc."},{"key":"7012_CR33","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe, G., Abraham, U. & Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 37, 4130\u20134146 (1994).","journal-title":"J. Med. Chem."},{"key":"7012_CR34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/v1031110","volume":"1","author":"IT Weber","year":"2009","unstructured":"Weber, I. T. & Agniswamy, J. HIV-1 protease: Structural perspectives on drug resistance. Viruses-Basel 1, 1110\u20131136 (2009).","journal-title":"Viruses-Basel"},{"key":"7012_CR35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/bi7018332","volume":"47","author":"RM Coman","year":"2008","unstructured":"Coman, R. M. et al. The contribution of naturally occurring polymorphisms in altering the biochemical and structural characteristics of HIV-1 subtype C protease. Biochemistry 47, 731\u2013743 (2008).","journal-title":"Biochemistry"},{"key":"7012_CR36","doi-asserted-by":"crossref","first-page":"15029","DOI":"10.1021\/bi035701y","volume":"42","author":"JC Clemente","year":"2003","unstructured":"Clemente, J. C., Hemrajani, R., Blum, L. E., Goodenow, M. A. & Dunn, B. A. Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N. Biochemistry 42, 15029\u201315035 (2003).","journal-title":"Biochemistry"},{"key":"7012_CR37","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1021\/bi051886s","volume":"45","author":"JC Clemente","year":"2006","unstructured":"Clemente, J. C. et al. Analysis of HIV-1CRF_01 A\/E protease inhibitor resistance: Structural determinants for maintaining sensitivity and developing resistance to atazanavir. Biochemistry 45, 5468\u20135477 (2006).","journal-title":"Biochemistry"},{"key":"7012_CR38","doi-asserted-by":"crossref","first-page":"12141","DOI":"10.1021\/bi049459m","volume":"43","author":"JC Clemente","year":"2004","unstructured":"Clemente, J. C. et al. Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease. Biochemistry 43, 12141\u201312151 (2004).","journal-title":"Biochemistry"},{"key":"7012_CR39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-2836(02)01139-7","volume":"324","author":"J Weber","year":"2002","unstructured":"Weber, J. et al. Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strains. J. Mol. Biol. 324, 739\u2013754 (2002).","journal-title":"J. Mol. Biol."},{"key":"7012_CR40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/abbi.2000.2017","volume":"382","author":"M Rinnova","year":"2000","unstructured":"Rinnova, M. et al. A picomolar inhibitor of resistant strains of human immunodeficiency virus protease identified by a combinatorial approach. Arch. Biochem. Biophys. 382, 22\u201330 (2000).","journal-title":"Arch. Biochem. Biophys."},{"key":"7012_CR41","doi-asserted-by":"crossref","first-page":"8810","DOI":"10.1128\/JVI.00451-09","volume":"83","author":"KG Saskova","year":"2009","unstructured":"Saskova, K. G. et al. Molecular characterization of clinical isolates of human immunodeficiency virus resistant to the protease inhibitor darunavir. J. Virol. 83, 8810\u20138818 (2009).","journal-title":"J. Virol."},{"key":"7012_CR42","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1110\/ps.036079.108","volume":"17","author":"KG Saskova","year":"2008","unstructured":"Saskova, K. G. et al. Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir. Protein Sci. 17, 1555\u20131564 (2008).","journal-title":"Protein Sci."},{"key":"7012_CR43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.antiviral.2008.01.009","volume":"78","author":"V Bartonova","year":"2008","unstructured":"Bartonova, V. et al. Potent inhibition of drug-resistant HIV protease variants by monoclonal antibodies. Antivir. Res. 78, 275\u2013277 (2008).","journal-title":"Antivir. Res."},{"key":"7012_CR44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jmb.2007.09.083","volume":"374","author":"M Kozisek","year":"2007","unstructured":"Kozisek, M. et al. Molecular analysis of the HIV-1 resistance development: Enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants. J. Mol. Biol. 374, 1005\u20131016 (2007).","journal-title":"J. Mol. Biol."},{"key":"7012_CR45","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic acids Res."},{"key":"7012_CR46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcc.20821","volume":"29","author":"K Wittayanarakul","year":"2008","unstructured":"Wittayanarakul, K., Hannongbua, S. & Feig, M. Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors. J. Comput. Chem. 29, 673\u2013685 (2008).","journal-title":"J. Comput. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07012-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07012-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:52:29Z","timestamp":1669330349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07012-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7012"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07012-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2913"}}